相关实验视频

Updated: Apr 7, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

功能性聚合物DNA纳米结构装饰的纤维素纳米晶体用于向和刺激响应药物输送

Yuyeon Lee¹, Keonwook Nam², Young Min Kim²

¹Graduate Program in Bioindustrial Engineering, College of Life Science and Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea.

Carbohydrate polymers

|June 10, 2024

概括

这项研究引入了聚合物DNA装饰的纤维素纳米晶体 (pDCs) 用于向癌症治疗. 这些混合纳米复合体提供刺激响应的药物释放,并表现出强大的抗癌特性,副作用最小.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
癌症治疗方法癌症治疗方法

背景情况:

纤维素纳米晶 (CNC) 是有前途的药物载体,但缺乏可编程性.
DNA纳米结构提供了适应性和刺激反应药物释放能力.
目前基于CNC的平台在向和控制药物输送方面面临局限性.

研究的目的:

开发一个多功能混合纳米复合平台,用于增强癌症治疗.
结合CNC和DNA纳米结构的优势,以实现向药物输送.
创建聚合物DNA装饰的CNCs (pDCs) 用于刺激响应和向的癌症治疗.

主要方法:

使用滚动圆放大 (RCA) 复制功能性DNA纳米结构.
通过静电相互作用,通过表面修饰的CNC与RCA生成的聚合物DNA复合,形成pDC.
pDC的特征,包括粒子大小,多分散性,泽塔潜力和生物稳定性.
针对癌症的细胞内输送和pH响应药物释放的体外评估.

主要成果:

聚合物DNA装饰的CNCs (pDCs) 已成功合成和表征.
pDCs证明了有效的癌症向细胞内传递.
实现了对pH响应的药物释放,展示了对刺激的响应能力.
pDC在体外表现出显著的抗癌特性,没有观察到副作用.

结论:

pDCs代表了一种具有多功能抗癌活动的新型混合纳米复合平台.
CNC和DNA纳米技术的结合克服了单个组件的局限性.
pDCs显示出开发先进的向癌症治疗的巨大潜力.

关键词:

纤维素纳米晶体纤维素纳米晶体在DNA纳米结构中.滚动圈放大器滚动圈放大器药物释放是响应刺激的药物.有针对性的药物输送.

更多相关视频

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

相关概念视频

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...